Business · 9 July 2026

FTSE 100 drops 0.6% as AstraZeneca falls 9.2%.

Kaihsu Tai via Wikimedia Commons (CC-BY-SA-3.0,2.5,2.0,1.0)

Investors faced weaker share prices as worries about the Middle East and a sharp drop in a major drug company weighed on the market. Britain's FTSE 100 lost 0.6% on Thursday, while the FTSE 250 added 0.1%. AstraZeneca dropped 9.2% after its late-stage Wainua trial didn't reach its main goal for reducing cardiovascular deaths and recurring heart problems.

By BriefTea Editorial · 9 July 2026 at 16:08

Reported by Reuters · How we write briefs

Get the app

Understand this story

What is the FTSE 100? FTSE 100 explained What's the FTSE 100?

More briefs

BusinessPound climbs to $1.3329 after strong August UK growth data BusinessIMF economist says UK should cut spending, not tax banks PoliticsHealey Rejects Mansion Tax Change That Would Double Homes Affected BusinessOfgem Plans Charge That Could Make Cheap Energy Deals Harder to Find BusinessBank of England's Bailey Says Inflation Pressures Subdued as Rate Rise Looms BusinessLockheed Martin may build UK's new £2bn Skynet satellites More business stories → Browse all stories →